APT Medical Inc Cash Flow Conversion Efficiency
APT Medical Inc cash flow conversion efficiency. Based on the latest financial reports, APT Medical Inc (688617) has a cash flow conversion efficiency ratio of 0.093x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥294.68 Million ≈ $43.12 Million USD) by net assets (CN¥3.18 Billion ≈ $465.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of APT Medical Inc (2017–2025)
Cash flow conversion efficiency of APT Medical Inc from 2017 to 2025. This chart illustrates how APT Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View APT Medical Inc stock price for real-time trading data and today's change.
APT Medical Inc Cash Flow Conversion Ratio Explained
APT Medical Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
APT Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of APT Medical Inc ranked by their cash flow conversion efficiency. Also see how much is APT Medical Inc worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZALANDO SE UNSP.ADR /2
F:ZAL1
|
N/A |
|
Hebei Yangyuan ZhiHui Beverage Co Ltd
SHG:603156
|
-0.058x |
|
Kuang Chi Technologies Co Ltd
SHE:002625
|
0.007x |
|
Giant Network Group Co Ltd
SHE:002558
|
0.069x |
|
Carlsberg A/S
CO:CARL-A
|
0.241x |
|
SHISEIDO CO. ADR
F:SHDA
|
0.045x |
|
Shan Dong Sun Paper Industry Joint Stock Co Ltd
SHE:002078
|
0.046x |
|
Perseus Mining Ltd
AU:PRU
|
0.180x |
Annual Cash Flow Conversion Efficiency for APT Medical Inc (2017–2025)
The table below shows the annual cash flow conversion efficiency of APT Medical Inc from 2017 to 2025. Review APT Medical Inc free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.18 Billion ≈ $465.03 Million |
CN¥975.30 Million ≈ $142.72 Million |
0.307x | +5.47% |
| 2024-12-31 | CN¥2.55 Billion ≈ $373.85 Million |
CN¥743.39 Million ≈ $108.78 Million |
0.291x | -17.15% |
| 2023-12-31 | CN¥1.96 Billion ≈ $287.10 Million |
CN¥689.06 Million ≈ $100.83 Million |
0.351x | +71.18% |
| 2022-12-31 | CN¥1.79 Billion ≈ $262.09 Million |
CN¥367.46 Million ≈ $53.77 Million |
0.205x | +102.58% |
| 2021-12-31 | CN¥1.79 Billion ≈ $262.09 Million |
CN¥181.39 Million ≈ $26.54 Million |
0.101x | -69.25% |
| 2020-12-31 | CN¥450.09 Million ≈ $65.86 Million |
CN¥148.24 Million ≈ $21.69 Million |
0.329x | +107.52% |
| 2019-12-31 | CN¥345.90 Million ≈ $50.62 Million |
CN¥54.90 Million ≈ $8.03 Million |
0.159x | +130.60% |
| 2018-12-31 | CN¥270.70 Million ≈ $39.61 Million |
CN¥18.63 Million ≈ $2.73 Million |
0.069x | +14.29% |
| 2017-12-31 | CN¥214.43 Million ≈ $31.38 Million |
CN¥12.91 Million ≈ $1.89 Million |
0.060x | -- |
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more